Home » Alzheimer, blood test to diagnose the disease: the study (also Italian)

Alzheimer, blood test to diagnose the disease: the study (also Italian)

by admin
Alzheimer, blood test to diagnose the disease: the study (also Italian)

One will suffice test of blood to detect the diseaseAlzheimer. The new diagnostic method was developed by a group of researchers also Italianfrom the University of Brescia together with colleagues from the University of Pittsburgh (United States) and the University of Gothenburg (Sweden).

their results, published in the journal «Brain»show that the new biomarker, based on an antibody that specifically binds to protein value produced in the brain, it surpasses current tests used to detect neurodegeneration related to Alzheimer’s.

Alzheimer’s, new Eisai and Biogen drug authorized in the United States: slows down cognitive decline. “Epochal Turn”

Alzheimer’s, a new less invasive test

Until now, a brain scan or analysis of cerebrospinal fluid was used to diagnose Alzheimer’s disease. But “these tests are expensive and many patients don’t have access to them,” says senior author Thomas Karikari, assistant professor of psychiatry at the University of Pittsburgh. Hence the need to develop less invasive and cheaper tests.

The team then developed a technique to selectively detect a special antibody, which when present in the blood, confirms the presence of the disease. This is “brain-derived tau” (BD-Year). The researchers validated their test on more than 600 patient samples including those whose diagnosis was confirmed after death and that of patients with early stage disease.

«We could now test new population groups»

The tests worked: they showed that the detected BD-tau levels matched the cerebrospinal fluid tau levels and reliably distinguished Alzheimer’s from other neurodegenerative diseases. They also correlated with the severity of amyloid plaques and tau tangles in brain tissue, confirmed by autopsy.

See also  Serena Williams: Unconventional Uses for Breast Milk

The usefulness of the research will allow not only to identify the disease early and more economically, but it will be possible to expand the studies on this disease. In fact, it will be easier for scientists to enroll patients belonging to population groups hitherto excluded from research into clinical trials.

Alzheimer’s disease, discovered new symptom linked to weight loss after 50 years

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy